Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Medical Liquid Embolic Agents Market Insights, Forecast to 2030

Global Medical Liquid Embolic Agents Market Insights, Forecast to 2030

Industry: Pharma & Healthcare

Published: 2024-12-21

Pages: 138 Pages

Report ld: 3407387

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Valued at US$ 143 million in 2024, the global Medical Liquid Embolic Agents market is forecast to reach US$ 222 million by 2030, at a CAGR of 7.6% during the forecast period.

Medical liquid embolic agents are specialized substances used in interventional radiology to block blood flow in targeted blood vessels, typically for treating vascular abnormalities such as arteriovenous malformations (AVMs), aneurysms, or tumors. These agents are delivered via a catheter and solidify or precipitate upon contact with blood or tissue, creating a durable embolization effect. Common types include cyanoacrylate glues, ethylene-vinyl alcohol copolymer (EVOH), and onyx-based systems, which vary in composition, viscosity, and application methods. They offer a minimally invasive treatment option, reducing the need for open surgery while providing precise vascular occlusion to manage bleeding or cut off blood supply to abnormal tissues.

Medical Liquid Embolic Agents Market Size

M= millions and B=billions

The US & Canada market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The China market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The Europe market for Medical Liquid Embolic Agents is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key manufacturers of Medical Liquid Embolic Agents include Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Medical Liquid Embolic Agents, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Medical Liquid Embolic Agents, also provides the sales of main regions and countries. of the upcoming market potential for Medical Liquid Embolic Agents, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Liquid Embolic Agents sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Medical Liquid Embolic Agents market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Medical Liquid Embolic Agents sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech, etc.

Market Segmentation

Report Metric
Details
Report Title
Global Medical Liquid Embolic Agents Market Insights, Forecast to 2030
Forecasted Market Size in 2030
US$ 222 million
CAGR(2024-2030)
7.6%
Market Size Available for Years
2019-2030
Global Medical Liquid Embolic Agents Companies Covered
Medtronic, Balt Group, Johnson & Johnson, Meril Life, BlackSwan Vascular, Success Bio-Tech
Global Medical Liquid Embolic Agents Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Medical Liquid Embolic Agents Market, Segment by Type
EVOH-Based

Diluted Cyanoacrylate

Others
Global Medical Liquid Embolic Agents Market, Segment by Application
Brain Arterio-Venous Malformations (bAVM)

Tumor Embolization

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Medical Liquid Embolic Agents in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Medical Liquid Embolic Agents manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Liquid Embolic Agents sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

Table of Contents

 1 Study Coverage
    1.1 Medical Liquid Embolic Agents Product Introduction
    1.2 Market by Type
        1.2.1 Global Medical Liquid Embolic Agents Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 EVOH-Based
        1.2.3 Diluted Cyanoacrylate
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Medical Liquid Embolic Agents Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Brain Arterio-Venous Malformations (bAVM)
        1.3.3 Tumor Embolization
        1.3.4 Others
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Executive Summary
    2.1 Global Medical Liquid Embolic Agents Revenue Estimates and Forecasts 2019-2030
    2.2 Global Medical Liquid Embolic Agents Revenue by Region
        2.2.1 Global Medical Liquid Embolic Agents Revenue by Region: 2019 VS 2023 VS 2030
        2.2.2 Global Medical Liquid Embolic Agents Revenue by Region (2019-2024)
        2.2.3 Global Medical Liquid Embolic Agents Revenue by Region (2025-2030)
        2.2.4 Global Medical Liquid Embolic Agents Revenue Market Share by Region (2019-2030)
    2.3 Global Medical Liquid Embolic Agents Sales Estimates and Forecasts 2019-2030
    2.4 Global Medical Liquid Embolic Agents Sales by Region
        2.4.1 Global Medical Liquid Embolic Agents Sales by Region: 2019 VS 2023 VS 2030
        2.4.2 Global Medical Liquid Embolic Agents Sales by Region (2019-2024)
        2.4.3 Global Medical Liquid Embolic Agents Sales by Region (2025-2030)
        2.4.4 Global Medical Liquid Embolic Agents Sales Market Share by Region (2019-2030)
    2.5 US & Canada
    2.6 Europe
    2.7 China
    2.8 Asia (excluding China)
    2.9 Middle East, Africa and Latin America

 3 Competition by Manufacturers
    3.1 Global Medical Liquid Embolic Agents Sales by Manufacturers
        3.1.1 Global Medical Liquid Embolic Agents Sales by Manufacturers (2019-2024)
        3.1.2 Global Medical Liquid Embolic Agents Sales Market Share by Manufacturers (2019-2024)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Medical Liquid Embolic Agents in 2023
    3.2 Global Medical Liquid Embolic Agents Revenue by Manufacturers
        3.2.1 Global Medical Liquid Embolic Agents Revenue by Manufacturers (2019-2024)
        3.2.2 Global Medical Liquid Embolic Agents Revenue Market Share by Manufacturers (2019-2024)
        3.2.3 Global Top 10 and Top 5 Companies by Medical Liquid Embolic Agents Revenue in 2023
    3.3 Global Key Players of Medical Liquid Embolic Agents, Industry Ranking, 2021 VS 2022
    3.4 Global Medical Liquid Embolic Agents Sales Price by Manufacturers (2019-2024)
    3.5 Analysis of Competitive Landscape
        3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.5.2 Global Medical Liquid Embolic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.6 Global Key Manufacturers of Medical Liquid Embolic Agents, Manufacturing Base Distribution and Headquarters
    3.7 Global Key Manufacturers of Medical Liquid Embolic Agents, Product Offered and Application
    3.8 Global Key Manufacturers of Medical Liquid Embolic Agents, Date of Enter into This Industry
    3.9 Mergers & Acquisitions, Expansion Plans

 4 Market Size by Type
    4.1 Global Medical Liquid Embolic Agents Sales by Type
        4.1.1 Global Medical Liquid Embolic Agents Historical Sales by Type (2019-2024)
        4.1.2 Global Medical Liquid Embolic Agents Forecasted Sales by Type (2025-2030)
        4.1.3 Global Medical Liquid Embolic Agents Sales Market Share by Type (2019-2030)
    4.2 Global Medical Liquid Embolic Agents Revenue by Type
        4.2.1 Global Medical Liquid Embolic Agents Historical Revenue by Type (2019-2024)
        4.2.2 Global Medical Liquid Embolic Agents Forecasted Revenue by Type (2025-2030)
        4.2.3 Global Medical Liquid Embolic Agents Revenue Market Share by Type (2019-2030)
    4.3 Global Medical Liquid Embolic Agents Price by Type
        4.3.1 Global Medical Liquid Embolic Agents Price by Type (2019-2024)
        4.3.2 Global Medical Liquid Embolic Agents Price Forecast by Type (2025-2030)

 5 Market Size by Application
    5.1 Global Medical Liquid Embolic Agents Sales by Application
        5.1.1 Global Medical Liquid Embolic Agents Historical Sales by Application (2019-2024)
        5.1.2 Global Medical Liquid Embolic Agents Forecasted Sales by Application (2025-2030)
        5.1.3 Global Medical Liquid Embolic Agents Sales Market Share by Application (2019-2030)
    5.2 Global Medical Liquid Embolic Agents Revenue by Application
        5.2.1 Global Medical Liquid Embolic Agents Historical Revenue by Application (2019-2024)
        5.2.2 Global Medical Liquid Embolic Agents Forecasted Revenue by Application (2025-2030)
        5.2.3 Global Medical Liquid Embolic Agents Revenue Market Share by Application (2019-2030)
    5.3 Global Medical Liquid Embolic Agents Price by Application
        5.3.1 Global Medical Liquid Embolic Agents Price by Application (2019-2024)
        5.3.2 Global Medical Liquid Embolic Agents Price Forecast by Application (2025-2030)

 6 US & Canada
    6.1 US & Canada Medical Liquid Embolic Agents Market Size by Type
        6.1.1 US & Canada Medical Liquid Embolic Agents Sales by Type (2019-2030)
        6.1.2 US & Canada Medical Liquid Embolic Agents Revenue by Type (2019-2030)
    6.2 US & Canada Medical Liquid Embolic Agents Market Size by Application
        6.2.1 US & Canada Medical Liquid Embolic Agents Sales by Application (2019-2030)
        6.2.2 US & Canada Medical Liquid Embolic Agents Revenue by Application (2019-2030)
    6.3 US & Canada Medical Liquid Embolic Agents Market Size by Country
        6.3.1 US & Canada Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030
        6.3.2 US & Canada Medical Liquid Embolic Agents Revenue by Country (2019-2030)
        6.3.3 US & Canada Medical Liquid Embolic Agents Sales by Country (2019-2030)
        6.3.4 US
        6.3.5 Canada

 7 Europe
    7.1 Europe Medical Liquid Embolic Agents Market Size by Type
        7.1.1 Europe Medical Liquid Embolic Agents Sales by Type (2019-2030)
        7.1.2 Europe Medical Liquid Embolic Agents Revenue by Type (2019-2030)
    7.2 Europe Medical Liquid Embolic Agents Market Size by Application
        7.2.1 Europe Medical Liquid Embolic Agents Sales by Application (2019-2030)
        7.2.2 Europe Medical Liquid Embolic Agents Revenue by Application (2019-2030)
    7.3 Europe Medical Liquid Embolic Agents Market Size by Country
        7.3.1 Europe Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030
        7.3.2 Europe Medical Liquid Embolic Agents Revenue by Country (2019-2030)
        7.3.3 Europe Medical Liquid Embolic Agents Sales by Country (2019-2030)
        7.3.4 Germany
        7.3.5 France
        7.3.6 U.K.
        7.3.7 Italy
        7.3.8 Russia

 8 China
    8.1 China Medical Liquid Embolic Agents Market Size by Type
        8.1.1 China Medical Liquid Embolic Agents Sales by Type (2019-2030)
        8.1.2 China Medical Liquid Embolic Agents Revenue by Type (2019-2030)
    8.2 China Medical Liquid Embolic Agents Market Size by Application
        8.2.1 China Medical Liquid Embolic Agents Sales by Application (2019-2030)
        8.2.2 China Medical Liquid Embolic Agents Revenue by Application (2019-2030)

 9 Asia (excluding China)
    9.1 Asia Medical Liquid Embolic Agents Market Size by Type
        9.1.1 Asia Medical Liquid Embolic Agents Sales by Type (2019-2030)
        9.1.2 Asia Medical Liquid Embolic Agents Revenue by Type (2019-2030)
    9.2 Asia Medical Liquid Embolic Agents Market Size by Application
        9.2.1 Asia Medical Liquid Embolic Agents Sales by Application (2019-2030)
        9.2.2 Asia Medical Liquid Embolic Agents Revenue by Application (2019-2030)
    9.3 Asia Medical Liquid Embolic Agents Market Size by Region
        9.3.1 Asia Medical Liquid Embolic Agents Revenue by Region: 2019 VS 2023 VS 2030
        9.3.2 Asia Medical Liquid Embolic Agents Revenue by Region (2019-2030)
        9.3.3 Asia Medical Liquid Embolic Agents Sales by Region (2019-2030)
        9.3.4 Japan
        9.3.5 South Korea
        9.3.6 China Taiwan
        9.3.7 Southeast Asia
        9.3.8 India
        9.3.9 Australia

 10 Middle East, Africa and Latin America
    10.1 Middle East, Africa and Latin America Medical Liquid Embolic Agents Market Size by Type
        10.1.1 Middle East, Africa and Latin America Medical Liquid Embolic Agents Sales by Type (2019-2030)
        10.1.2 Middle East, Africa and Latin America Medical Liquid Embolic Agents Revenue by Type (2019-2030)
    10.2 Middle East, Africa and Latin America Medical Liquid Embolic Agents Market Size by Application
        10.2.1 Middle East, Africa and Latin America Medical Liquid Embolic Agents Sales by Application (2019-2030)
        10.2.2 Middle East, Africa and Latin America Medical Liquid Embolic Agents Revenue by Application (2019-2030)
    10.3 Middle East, Africa and Latin America Medical Liquid Embolic Agents Market Size by Country
        10.3.1 Middle East, Africa and Latin America Medical Liquid Embolic Agents Revenue by Country: 2019 VS 2023 VS 2030
        10.3.2 Middle East, Africa and Latin America Medical Liquid Embolic Agents Revenue by Country (2019-2030)
        10.3.3 Middle East, Africa and Latin America Medical Liquid Embolic Agents Sales by Country (2019-2030)
        10.3.4 Brazil
        10.3.5 Mexico
        10.3.6 Turkey
        10.3.7 Israel
        10.3.8 GCC Countries

 11 Corporate Profile
    11.1 Medtronic
        11.1.1 Medtronic Company Information
        11.1.2 Medtronic Overview
        11.1.3 Medtronic Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
        11.1.4 Medtronic Medical Liquid Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Medtronic Recent Developments
    11.2 Balt Group
        11.2.1 Balt Group Company Information
        11.2.2 Balt Group Overview
        11.2.3 Balt Group Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
        11.2.4 Balt Group Medical Liquid Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Balt Group Recent Developments
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Information
        11.3.2 Johnson & Johnson Overview
        11.3.3 Johnson & Johnson Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
        11.3.4 Johnson & Johnson Medical Liquid Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Johnson & Johnson Recent Developments
    11.4 Meril Life
        11.4.1 Meril Life Company Information
        11.4.2 Meril Life Overview
        11.4.3 Meril Life Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
        11.4.4 Meril Life Medical Liquid Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Meril Life Recent Developments
    11.5 BlackSwan Vascular
        11.5.1 BlackSwan Vascular Company Information
        11.5.2 BlackSwan Vascular Overview
        11.5.3 BlackSwan Vascular Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
        11.5.4 BlackSwan Vascular Medical Liquid Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 BlackSwan Vascular Recent Developments
    11.6 Success Bio-Tech
        11.6.1 Success Bio-Tech Company Information
        11.6.2 Success Bio-Tech Overview
        11.6.3 Success Bio-Tech Medical Liquid Embolic Agents Sales, Price, Revenue and Gross Margin (2019-2024)
        11.6.4 Success Bio-Tech Medical Liquid Embolic Agents Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Success Bio-Tech Recent Developments

 12 Industry Chain and Sales Channels Analysis
    12.1 Medical Liquid Embolic Agents Industry Chain Analysis
    12.2 Medical Liquid Embolic Agents Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Medical Liquid Embolic Agents Production Mode & Process
    12.4 Medical Liquid Embolic Agents Sales and Marketing
        12.4.1 Medical Liquid Embolic Agents Sales Channels
        12.4.2 Medical Liquid Embolic Agents Distributors
    12.5 Medical Liquid Embolic Agents Customers

 13 Medical Liquid Embolic Agents Market Dynamics
    13.1 Medical Liquid Embolic Agents Industry Trends
    13.2 Medical Liquid Embolic Agents Market Drivers
    13.3 Medical Liquid Embolic Agents Market Challenges
    13.4 Medical Liquid Embolic Agents Market Restraints

 14 Key Findings in the Global Medical Liquid Embolic Agents Study

 15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer

Table of Figures